Summary of Purpose
Endovascular treatment has recently become the recommended therapy for acute stroke after the publication of five randomized trials (MR CLEAN1, ESCAPE2, EXTEND IA3, SWIFT PRIME4, REVASCAT5) in 2015 that demonstrate its efficacy. Hospitals need to adapt to these updated stroke care guidelines, and many hospitals are not appropriately equipped for neurointerventional procedures. Decreased time to treatment is...Read More →
The following dates are available for this trial. Trial information last updated on 26 February 2018.
|1 Jun 2016||7 Feb 2017||1 Dec 2018||1 Dec 2018||1 Feb 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|